NCT03463005

Brief Summary

The present Pocock clinical trial study was conducted In the city of Mashhad in Iran between 2015 and 2016. The study inclusion criteria were men with low fertility of sperm motility\<25% and total motility \<50% (asthenozoospermia), no history of endocrine diseases, no diabetes men, no hormonal problems in their wives, and a healthy salpingography in their wives. The study subjects were voluntarily assigned to royal gel and IUI groups. In royal gel group, 5 grams of royal gel was used after menstruation and every other night before and after intercourse. IUI group received 75 units of FSH from the second day of the cycle. Then vaginal ultrasound was performed from the sixth day of menstrual cycle to determine the right size of follicle. 10000 units of HCG was administered when follicle diameter reached 16mm, and the study subject was prepared for IUI 32-36 hours later. Each subject alternately swapped groups following fertility failure.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 10, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

March 13, 2018

Completed
Last Updated

March 13, 2018

Status Verified

March 1, 2018

Enrollment Period

1.7 years

First QC Date

February 18, 2018

Last Update Submit

March 6, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Occurrence of pregnancy

    Occurrence of pregnancy be detected by B-HCG test

    Three months after intervention

Secondary Outcomes (1)

  • confirmation of pregnancy

    Three months after intervention

Study Arms (2)

Royal jelly

EXPERIMENTAL

The study subjects included healthy women who had husbands with male-factor infertility problems.

Other: Royal jelly

IUI group

ACTIVE COMPARATOR

The study subjects included in IUI group were healthy women who had husbands with male-factor infertility problems.

Procedure: IUI

Interventions

The study subjects in the Royal jelly group used 10 ml of the vaginal Royal jell few minutes before and few minutes after intercourse one day after the end of menstruation for two weeks.

Also known as: Complementary group
Royal jelly
IUIPROCEDURE

Subjects in IUI group received 75 units of FSH from the second day of the cycle.

IUI group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male-factor infertility (defined as total sperm motility\<40% and sperm motility\<20%)
  • Normal hormonal profile in women
  • Normal hysterosalpingography report
  • Regular sexual relationships

You may not qualify if:

  • Ovulation dysfunction
  • History of sexually transmitted diseases in women and men
  • Hormonal disorders in men and women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Asthenozoospermia

Interventions

royal jelly

Condition Hierarchy (Ancestors)

Infertility, MaleGenital Diseases, MaleGenital DiseasesUrogenital DiseasesInfertilityMale Urogenital Diseases

Study Officials

  • Tahereh Fathi Najafi, Instructor

    Midwifery department, Islamic Azad Medical University, Mashhad branc, Mashhad, Iran

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The study subjects were voluntarily assigned to royal gel and IUI groups. In royal gel group, 5 grams of royal gel was used after menstruation and every other night before and after intercourse. IUI group received 75 units of FSH from the second day of the cycle.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr Narjes Bahri

Study Record Dates

First Submitted

February 18, 2018

First Posted

March 13, 2018

Study Start

January 1, 2016

Primary Completion

September 20, 2017

Study Completion

December 10, 2017

Last Updated

March 13, 2018

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share